Brain Neoplasms

"Brain Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Descriptor ID	D001932
MeSH Number(s)	C04.588.614.250.195 C10.228.140.211 C10.551.240.250
Concept/Terms	Brain Neoplasms Brain Neoplasms Neoplasms, Brain Brain Neoplasm Neoplasm, Brain Brain Tumors Brain Tumor Tumor, Brain Tumors, Brain Brain Cancer Brain Cancer Brain Cancers Cancer, Brain Cancers, Brain Malignant Neoplasms, Brain Brain Malignant Neoplasm Brain Malignant Neoplasms Malignant Neoplasm, Brain Cancer of Brain Cancer of the Brain Neoplasms, Brain, Malignant Brain Neoplasms, Malignant Brain Neoplasm, Malignant Malignant Brain Neoplasm Malignant Brain Neoplasms Neoplasms, Intracranial Neoplasms, Intracranial Intracranial Neoplasm Neoplasm, Intracranial Intracranial Neoplasms Brain Tumor, Recurrent Brain Tumor, Recurrent Brain Tumors, Recurrent Recurrent Brain Tumor Recurrent Brain Tumors Malignant Primary Brain Tumors Malignant Primary Brain Tumors Primary Malignant Brain Tumors Malignant Primary Brain Neoplasms Primary Malignant Brain Neoplasms Brain Neoplasms, Malignant, Primary Brain Neoplasms, Primary Malignant Benign Neoplasms, Brain Benign Neoplasms, Brain Benign Neoplasm, Brain Brain Benign Neoplasm Brain Benign Neoplasms Neoplasms, Brain, Benign Brain Neoplasms, Benign Benign Brain Neoplasm Benign Brain Neoplasms Brain Neoplasm, Benign Brain Tumor, Primary Brain Tumor, Primary Brain Tumors, Primary Primary Brain Tumor Primary Brain Tumors Neoplasms, Brain, Primary Brain Neoplasm, Primary Brain Neoplasms, Primary Primary Brain Neoplasm Primary Brain Neoplasms

Below are MeSH descriptors whose meaning is more general than "Brain Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Nervous System Neoplasms [C04.588.614]
Central Nervous System Neoplasms [C04.588.614.250]
Brain Neoplasms [C04.588.614.250.195]
Nervous System Diseases [C10]
Central Nervous System Diseases [C10.228]
Brain Diseases [C10.228.140]
Brain Neoplasms [C10.228.140.211]
Nervous System Neoplasms [C10.551]
Central Nervous System Neoplasms [C10.551.240]
Brain Neoplasms [C10.551.240.250]

Below are MeSH descriptors whose meaning is more specific than "Brain Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Brain Neoplasms" by people in this website by year, and whether "Brain Neoplasms" was a major or minor topic of these publications.

Bar chart showing 377 publications over 30 distinct years, with a maximum of 24 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	16	0	16
1997	16	2	18
1998	10	1	11
1999	10	1	11
2000	4	1	5
2001	11	2	13
2002	3	1	4
2003	6	2	8
2004	8	0	8
2005	12	2	14
2006	13	1	14
2007	12	3	15
2008	14	1	15
2009	18	0	18
2010	16	1	17
2011	10	2	12
2012	12	3	15
2013	11	1	12
2014	18	2	20
2015	18	0	18
2016	9	2	11
2017	10	3	13
2018	13	2	15
2019	23	1	24
2020	11	1	12
2021	11	1	12
2022	6	1	7
2023	10	0	10
2024	7	0	7
2025	2	0	2

Below are the most recent publications written about "Brain Neoplasms" by people in Profiles.

Akbari H, Bakas S, Sako C, Fathi Kazerooni A, Villanueva-Meyer J, Garcia JA, Mamourian E, Liu F, Cao Q, Shinohara RT, Baid U, Getka A, Pati S, Singh A, Calabrese E, Chang S, Rudie J, Sotiras A, LaMontagne P, Marcus DS, Milchenko M, Nazeri A, Balana C, Capellades J, Puig J, Badve C, Barnholtz-Sloan JS, Sloan AE, Vadmal V, Waite K, Ak M, Colen RR, Park YW, Ahn SS, Chang JH, Choi YS, Lee SK, Alexander GS, Ali AS, Dicker AP, Flanders AE, Liem S, Lombardo J, Shi W, Shukla G, Griffith B, Poisson LM, Rogers LR, Kotrotsou A, Booth TC, Jain R, Lee M, Mahajan A, Chakravarti A, Palmer JD, DiCostanzo D, Fathallah-Shaykh H, Cepeda S, Santonocito OS, Di Stefano AL, Wiestler B, Melhem ER, Woodworth GF, Tiwari P, Valdes P, Matsumoto Y, Otani Y, Imoto R, Aboian M, Koizumi S, Kurozumi K, Kawakatsu T, Alexander K, Satgunaseelan L, Rulseh AM, Bagley SJ, Bilello M, Binder ZA, Brem S, Desai AS, Lustig RA, Maloney E, Prior T, Amankulor N, Nasrallah MP, O'Rourke DM, Mohan S, Davatzikos C. Machine learning-based prognostic subgrouping of glioblastoma: A multicenter study. Neuro Oncol. 2025 May 15; 27(4):1102-1115.

View in: PubMed
Lasota J, Kaczorowski M, Chlopek M, Milek-Krupa J, Szczepaniak M, Ylaya K, Chodyna M, Izycka-Swieszewska E, Scherping A, Czapiewski P, Dziuba I, Kato Y, Halon A, Kowalik A, Miettinen M. An immunohistochemical and molecular genetic study of 60 colorectal carcinoma brain metastases in pursuit of predictive biomarkers for cancer therapy. Hum Pathol. 2025 Jan; 155:105717.

View in: PubMed
Carey P, Gardner C, Uppendahl A, Kantor J, Cappelli L, Alnahhas I, Andrews D, Daskalakis C, Shi W. Body mass index as a prognostic indicator of overall survival in glioblastoma: A systematic review and meta analysis. J Clin Neurosci. 2025 Mar; 133:111019.

View in: PubMed
McIlvain G, Hayes LL, Walter AW, Averill LW, Kandula V, Johnson CL, Nikam RM. Mechanical properties of pediatric low-grade gliomas in children with and without neurofibromatosis type 1. Neuroradiology. 2024 Dec; 66(12):2301-2311.

View in: PubMed
Ivanidze J, Sharbatdaran A, McCalla A, Brandmaier A, Andreopoulou E, Cristofanilli M, Cigler T, Balogun OD, Magge RS, Liechty B, Karakatsanis NA, Nehmeh SA, Agee MA, Jean J, Osborne JR, Beal K, Schwartz TH, Pannullo SC, Knisely JPS, Ramakrishna R. [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases. Eur J Radiol. 2024 Dec; 181:111791.

View in: PubMed
Ajmal N, Deng Y, Kenyon LC, Curtis MT, Dispagna M, Izes J, Li L. Metastatic prostate adenocarcinoma to the brain - a clinicopathologic analysis of 21 cases. Diagn Pathol. 2024 Oct 01; 19(1):132.

View in: PubMed
Essien M, Cooper ME, Gore A, Min TL, Risk BB, Sadigh G, Hu R, Hoch MJ, Weinberg BD. Interrater Agreement of BT-RADS for Evaluation of Follow-up MRI in Patients with Treated Primary Brain Tumor. AJNR Am J Neuroradiol. 2024 09 09; 45(9):1308-1315.

View in: PubMed
Weinberg BD, Hoch MJ. Brain Tumor-Radiology and Data System (BT-RADS)-an imperfect system but a worthwhile start. Eur Radiol. 2024 Oct; 34(10):6782-6784.

View in: PubMed
Cappelli L, Uppendahl A, Gardner C, Khan M, Kayne A, Vemula S, Poiset SJ, Zhan T, Judy KD, Andrews DW, Simone NL, Alnahhas I, Shi W. Baseline single institutional retrospective review of body mass index (BMI) as a prognostic indicator in patients with newly diagnosed glioblastoma (GBM). J Clin Neurosci. 2024 Sep; 127:110754.

View in: PubMed
Lee IY, Hanft S, Schulder M, Judy KD, Wong ET, Elder JB, Evans LT, Zuccarello M, Wu J, Aulakh S, Agarwal V, Ramakrishna R, Gill BJ, Qui?ones-Hinojosa A, Brennan C, Zacharia BE, Silva Correia CE, Diwanji M, Pennock GK, Scott C, Perez-Olle R, Andrews DW, Boockvar JA. Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients. Future Oncol. 2024 Mar; 20(10):579-591.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement